Similar serum levels of IL-6 and its soluble receptors in patients with HCV-related arthritis and rheumatoid arthritis: A pilot study

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 281-285

  Riccio, A ^a   Postiglione, L ^b   Sabatinp, P ^b   Linvelli, M ^b   Soriente, I ^b   Sangiolo, M G ^a   Amato, P ^b   Tarantino, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ASL SA 1   (Italy)

Author keywords

HCV related arthritis; Interleukin 6; Rheumatoid arthritis

Indexed keywords

AMINOTRANSFERASE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; GLYCOPROTEIN GP 130;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; VIREMIA; ARTHRITIS; CYTOKINE PRODUCTION; HEPATITIS C VIRUS RELATED ARTHRITIS; HUMAN TISSUE; LIVER BIOPSY; MIDDLE AGED;

EID: 84861469829     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500132     Document Type: Article

References (25)

1. Kishimoto T. Interleukin 6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol 2005; 23:1-21. (Pubitemid 40563163)
2. Koch AE, Kunkel SL, Strieter RM. Cytokines in rheumatoid arthritis. J Invest Med 1995; 43:28-38.
3. Koch AE. Angiogenesis: Implications for rheumatoid arthritis. Arthritis Rheum 1998; 41:951-62. (Pubitemid 28265398)
4. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147:117-23.
5. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13:139-45.
6. Heinrich PC, Behrmann I, Haan S, Hermanns HS, Mueller-Newen G, Schaper F. Principles of interleukin(IL)-6-type cytokine signaling and its regulation. Biochem J 2003; 374:1-20. (Pubitemid 37046923)
7. Rose-John S, Ehlers M, Grotzinger J, Mullberg J. The soluble interleukin 6 receptor. Ann NY Acad Sci 1995; 762:207-20.
8. MHeinrich PC, Graeve L, Rose-John S, et al. Membrane-bound and soluble interleukin 6 receptor: Studies on structure, regulation of expression and signal transduction. Ann NY Acad Sci 1995; 762: 222-36.
9. Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T. Soluble forms of the interleukin-6-signal- transducing receptor component gp130 in human serum possessing a potential to inhibit through membrane-anchored gp-30. Blood 1993; 82:1120-6. (Pubitemid 23253984)
10. Jones SA, Richards PJ, Scheller J, Rose-John S. IL-6 transsignalling: the in vivo consequences. J Interferon Cytokine Res 2005; 25:241-53.
11. Memoli B, Grandaliano G, Soccio et al. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD. J Am Soc Nephrol 2005; 16:1099-107. (Pubitemid 41710321)
12. Robak T, Gladalska A, Stepien A, Robak E. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediators Inflamm 1998; 7:347-53. (Pubitemid 28552768)
13. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J. Interleukin-6, soluble interleukin-2 receptor and soluble Interleukin-6 receptor in the sera of patients different histological patterns of rheumatoid synovitis. Clin Exp Rheumatol 2003; 21:63-9. (Pubitemid 36267533)
14. Cronstein BN. Interleukin-6. A key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp J Dis 2007; 65:11-5.
15. De Benedetti F, De Pasquale L, Bugatti S, Montecucco C. Interleuchina 6 e infiammazione cronica nell'artrite reumatoide. Reumatismo 2008; 60:1-7.
16. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31:784-8.
17. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000; 12:295-9. (Pubitemid 30439683)
18. Pyrsopoulos NT, Reddy KR. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep 2001; 3:71-8.
19. Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15:382-8.
20. Migita K, Abiru S, Maeda Y, et al. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 2006; 67:27-33.
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24. (Pubitemid 18091653)
22. Riccio A, Postiglione L, La Dogana P, Spanò A, Marzocchella C, Tarantino G. Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents 2008; 22:57-61. (Pubitemid 351577893)
23. Tarantino G, Riccio A, Spano A, Loi G, Padula S, Ladogana P, Scarpa. HCV infection and chronic arthritis: Does viral replicaton matter? Hepatol Res 2006; 35:238-41. (Pubitemid 44138494)
24. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovski HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21:613-9.
25. Breen EC, Gage JR, Guo B, Magpantay L, Narazaki M, Kishimoto T, Miles S, Martinez-Maza O. Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6. Cell Immunol 2001; 212:118-25. (Pubitemid 34044543)